Siegfried successfully places Senior Bonds of CHF 200 million
(SIX/SFZN) Siegfried Holding AG has today successfully placed Senior Bonds in the amount of CHF 200 million. The Bonds will have a maturity of 5 years and a coupon of 0.20%. The proceeds will be used for general corporate purposes, including the early refinancing of a Hybrid Bond of CHF 160 million callable in October 2021.
Siegfried will file an application for the Senior Bonds to be admitted for listing and trading on the SIX Swiss Exchange. The settlement date is expected to be June 15, 2021.
CFO Reto Suter: “With this successful placement of the Senior Bonds, a first for Siegfried, we optimize our funding mix and retain the strategic flexibility required.”
The bonds attracted strong interest among Swiss investors and were placed under the lead of UBS AG.
About Siegfried
The Siegfried Group is a global life sciences company with sites in Switzerland, Germany, Spain, France, Malta, the USA and China. In 2020, the Siegfried Group achieved sales of CHF 845.1 million. Currently it employs approximately 3’500 people at eleven sites on three continents. Siegfried Holding AG is publicly listed on SIX Swiss Exchange (SIX: SFZN).
The Siegfried Group is active in both the primary and secondary production of drugs, develops and manufactures active pharmaceutical ingredients and intermediates for the research-based pharmaceutical industry and provides development and production services for drugs in finished dosage forms including sterile filling.
